Cannabis use linked to increased risk of heart attack and stroke
Analysis of over 430,000 adults in the United States has unveiled concerning connections between cannabis consumption and heightened risks of heart attack and stroke.
How can cannabis help with chronic pain?
A staggering 51.6 million Americans live with pain daily; Ellen Smith from the U.S. Pain Foundation tells us about how medical cannabis supports her management of chronic pain.
Secarna: Next generation antisense therapeutics
Leading independent European antisense drug discovery company, Secarna, aims to bring novel and effective antisense therapeutic options to an increasing number of patients. CEO Alexander Gebauer tells us how.
Medicinal cannabis: The future of chronic pain treatment?
Alberto Sainz Cort to discuss the prevalence of chronic pain and opioid use in the United States, as well as medical cannabis as a potential treatment for pain.
Antibiotic resistance threatens young lives worldwide
Antibiotics used to treat common infections in infants and children are becoming increasingly ineffective worldwide.
CBD and growing trust: Sowing the seeds of good health
Over the past seven years, CBD wellness company Savage Cabbage has grown from a small family-run business into a globally recognised, high-quality brand, trusted as an authoritative voice, even in the corridors of Westminster.
Cannabis use disorder linked to increased cardiovascular disease risk
A study highlights a 60% increased cardiovascular disease risk in individuals with cannabis use disorder, concerns about heart attacks.
Finger sweat test detects antipsychotic drugs in patients
Innovative finger sweat test provides patients with a more comfortable and non-invasive way to monitor antipsychotic drug levels.
£5 million fund to combat fatal drug deaths in the UK
In a concerted effort to combat the alarming issue of fatal drug deaths across the UK, the government has allocated £5 million to support 12 groundbreaking projects.
Innovative paediatric research: Investigating the 3D printing of medication
The NIH has awarded a grant of $3 million in the hope of supporting the 3D printing of medication tailored towards helping paediatric patients.
How can connected drug delivery devices help patients adhere to their therapies?
Poor adherence to drug therapies can lead to medication waste and poor patient outcomes. Tim Wooller shares some of the reasons behind poor adherence to medication and how connected drug delivery devices can help.
Advancing animal rights
With a particular focus on South Korea, Open Access Government explores the changing perceptions around animal welfare and some of the policies introduced to support this.
Reducing wasted medicines: Beyond net zero to sustainable healthcare
Dr Nazneen Rahman, Founder and CEO of YewMaker and Sustainable Medicines Partnership (SMP) Director describes how tackling wasted medicines is crucial to achieving sustainable healthcare.
CBD benefits to help you take control of your health
Savage Cabbage Ltd discuss CBD benefits and how they specifically work to aid anxiety, stress, sleep problems and menopause symptoms.
Robotic pill safely delivers injectable Osteoporosis drug
A groundbreaking study demonstrates the efficacy of administering a previously injection-only medication for osteoporosis through an innovative robotic pill.
AI and anti-aging research: Unveiling the latest drug discovery
AI and Anti-aging research: According to a study, AI algorithms (AI) has led to the discovery of three drugs that have the potential to delay the effects of aging.
Phasing out the use of animals in science
Barney Reed, Senior Scientific Manager, Animals in Science Department at the RSPCA, stresses the need for ambitious strategies for phasing out the use of animals in science.
Could blockchain solve pharma’s supply management woes?
Blockchain wasn’t invented as a supply management tool; yet, today it is helping to solve some of the most complex problems existing in global supply chains.
Phasing out the use of animals in science
Barney Reed, Senior Scientific Manager, Animals in Science Department at the RSPCA, stresses the need for ambitious strategies for phasing out the use of animals in science.
Lack of access to treatment for opioid dependence is concerning
Monica Racoviță, Senior Researcher at The Health Policy Partnership, argues that opioid dependence is a pressing issue, yet treatment for it is still out of reach for many.